Nasal Glucagon for the Treatment of Moderate-to-Severe Hypoglycemic Episodes in Real-World Settings in Adults with Type 1 Diabetes

被引：0
|
作者：
Seaquist, Elizabeth R.
Dulude, Helene
Zhang, Michelle X.
Rampakakis, Emmanouil
Rabasa-Lhoret, Remi
Tsoukas, George M.
Conway, J. Robin
Weisnagel, S. John
Gerety, Gregg
Woo, Vincent
Zhang, Shuyu
Carballo, Dolores
Triest, Myriam
Piche, Claude A.
Guzman, Cristina B.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
357-OR
引用
收藏
页码：A94 / A94
页数：1
相关论文
共 50 条
  • [1] Nasal glucagon for the treatment of moderate-to-severe hypoglycaemic episodes in real-world settings in adults with type 1 diabetes
    Seaquist, E. R.
    Dulude, H.
    Zhang, M. X.
    Rampakakis, E.
    Rabasa-Lhoret, R.
    Tsoukas, G. M.
    Conway, J. R.
    Weisnagel, S. J.
    Gerety, G.
    Woo, V.
    Zhang, S.
    Carballo, D.
    Triest, M.
    Piche, C. A.
    Guzman, C. B.
    [J]. DIABETOLOGIA, 2017, 60 : S338 - S339
  • [2] Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting
    Seaquist, Elizabeth R.
    Dulude, Helene
    Zhang, Xiaotian M.
    Rabasa-Lhoret, Remi
    Tsoukas, George M.
    Conway, James R.
    Weisnagel, Stanley J.
    Gerety, Gregg
    Woo, Vincent C.
    Zhang, Shuyu
    Carballo, Dolores
    Pradhan, Sheetal
    Piche, Claude A.
    Guzman, Cristina B.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1316 - 1320
  • [3] Nasal glucagon for the treatment of moderate to severe hypoglycaemia episodes in children and adolescents with type 1 diabetes in home or school settings
    Guzman, C. B.
    Deeb, L.
    Dulude, H.
    Zhang, M.
    Zhang, S.
    Reiner, B. J.
    Piche, C. A.
    [J]. DIABETOLOGIA, 2017, 60 : S337 - S338
  • [4] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [5] Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data
    Xiao, Y.
    Lakatos, P. L.
    Bourdages, R.
    Bitton, A.
    Afif, W.
    Kohen, R.
    Berberi, M.
    Bessissow, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S445 - S445
  • [6] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
  • [7] Real-world disease burden in US adults with moderate-to-severe atopic dermatitis eligible for treatment with systemic immunosuppressants
    Armstrong, April
    Moon, Rachel
    Bell, David
    Blackburn, Stuart
    Wei, Wenhui
    Chao, Jingdong
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB215 - AB215
  • [8] A "REAL-WORLD" CHARACTERIZATION OF MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS
    Strand, V.
    Johnson, J.
    Vandeloo, C.
    Galateanu, C.
    Lobosco, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 626 - 627
  • [9] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    Huang, He
    Cai, Ming-Long
    Hong, Xiao-Jie
    Zheng, Li-Jun
    Hu, Zhu-Lin
    Yuan, Tao
    Li, Wei-Ran
    Sheng, Yu-Jun
    Zhang, Xue-Jun
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 554 - 560
  • [10] Comparison of the disease survival of biologics for the treatment of moderate-to-severe psoriasis: real-world data
    Oh, S-M
    Kang, K-W
    Kang, D-H
    Kwon, S-H
    Lew, B-L
    Shin, M. K.
    Jeong, K-H
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S343 - S343
12345